M10.4
Other secondary gout
Clinical Classification Guidelines
Code First
- associated condition
Medical Intelligence & Overview
Other secondary gout, classified under ICD-10 code M10.4, is a form of gout that arises due to underlying health conditions or factors that lead to increased uric acid levels in the body. Unlike primary gout, which is mainly caused by genetic factors, secondary gout results from other health issues or lifestyle choices. It is characterized by the accumulation of uric acid crystals in joints and tissues, leading to inflammation and pain. Recognizing and managing secondary gout is important for preventing joint damage and improving quality of life.
Causes & Symptoms
Clinical Causes: Chronic kidney disease, which impairs uric acid excretion Use of certain medications like diuretics, aspirin, or immunosuppressants Metabolic conditions such as obesity and insulin resistance Excessive alcohol consumption High-purine diet, including red meats and seafood Other medical conditions that affect uric acid metabolism
Key Symptoms: Sudden and intense joint pain, often in the big toe, but can also involve ankles, knees, wrists, or elbows Swelling and redness around affected joints Heat sensation in the affected area Tenderness that worsens with movement or pressure Lingering discomfort even after initial pain subsides Possible formation of tophi, chalky deposits of uric acid crystals beneath the skin over time
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of clinical evaluation and laboratory tests. A healthcare provider may perform joint fluid analysis by extracting fluid from the affected joint to look for uric acid crystals. Blood tests to measure uric acid levels can support the diagnosis, although levels can sometimes be normal during an attack. Imaging studies, such as X-rays or ultrasound, may reveal joint damage or tophi. The overall assessment helps distinguish secondary gout from other types of arthritis and joint conditions.
Treatment Protocols: Management strategies aim to reduce inflammation, relieve pain, and control uric acid levels. Common approaches include: - **Medications for acute gout attacks:** Nonsteroidal anti-inflammatory drugs (NSAIDs), colchicine, or corticosteroids to reduce inflammation and pain. - **Long-term uric acid management:** Medications such as allopurinol or febuxostat to lower uric acid production, and probenecid to increase uric acid excretion. - **Lifestyle modifications:** Dietary changes to limit high-purine foods, reduce alcohol intake, and maintain a healthy weight. - **Addressing underlying causes:** Managing conditions like kidney disease or adjusting medications that may contribute to hyperuricemia. Consultation with healthcare professionals is essential for tailored treatment plans and ongoing management.
Clinical Advice & FAQs
Billing Guidance
Is M10.4 a billable ICD-10 code?
Yes, M10.4 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M10.4?
Clinical documentation must specify the nature of Other secondary gout and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
